12:00 AM
 | 
Oct 01, 2001
 |  BioCentury  |  Finance

Europe's cash position

Europe's cash position

Company 6/31 cash ended (A) 6 month EBITDA at 6/30 (B) Imputed years of cash 9/21mkt cap
Actelion (SWX:ATLN) $138.9M ($19.6M) 3.5 $530.9M
Antisoma (LSE:ASM) (C)...

Read the full 206 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >